BioCentury | Nov 30, 2018
Financial News

Pharmasset, Idenix vets lead HBV company Antios to $25M series A

...Other investors included CAM Capital, Delos Capital, Quantum Vista Capital, Fonds de solidarité FTQ and Georgia Research Alliance Venture Fund...
BioCentury | Nov 27, 2018
Financial News

Pharmasset, Idenix vets lead HBV company Antios to $25M series A

...Other investors included CAM Capital, Delos Capital, Quantum Vista Capital, Fonds de solidarité FTQ and Georgia Research Alliance Venture Fund...
BioCentury | Dec 7, 2015
Financial News

Clearside Biomedical completes venture financing

...Cormorant Asset Management; Perceptive Advisors; Rock Springs Capital; RusnanoMedInvest; Hatteras Venture Partners; Mountain Group Capital; Georgia Research Alliance Venture Fund WIR...
BioCentury | Dec 4, 2015
Financial News

Clearside's series C brings $20M

...Springs Capital as well as existing investors RusnanoMedInvest, Hatteras Venture Partners, Mountain Group Capital and Georgia Research Alliance Venture Fund...
BioCentury | Jun 15, 2015
Financial News

Celtaxsys Inc. completes venture financing

...Type: Venture financing Raised: $40 million Investors: Domain Associates; Lumira Capital; RMI Partners; Masters Capital; Georgia Research Alliance Venture Fund...
BioCentury | Jun 15, 2015
Finance

Domain finds unmet need in CF

...Other investors in the round included Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund...
BioCentury | Jun 9, 2015
Financial News

Celtaxsys raises $40 million series D

...its Fund VIII. Also participating were Lumira Capital; RMI Partners; Masters Capital Management; and the Georgia Research Alliance Venture Fund...
BioCentury | Sep 8, 2014
Financial News

Clearside Biomedical completes venture financing

...$16 million Investors: RusnanoMedInvest; Hatteras Venture Partners; Santen Pharmaceutical Co. Ltd. ; Mountain Group Capital; Georgia Research Alliance Venture Fund WIR...
BioCentury | Sep 3, 2014
Financial News

Clearside raises $16 million B round

...RusnanoMedInvest. Existing investors Hatteras Venture Partners; Santen Pharmaceuticals Co. Ltd. (Tokyo:4536); Mountain Group Capital; and Georgia Research Alliance Venture Fund...
BioCentury | Feb 11, 2013
Financial News

Clearside Biomedical completes venture financing

...Raised: $7.9 million Investors: Santen Pharmaceutical Co. Ltd. ; Mountain Group Capital; Hatteras Venture Partners; Georgia Research Alliance Venture Fund...
Items per page:
1 - 10 of 10
BioCentury | Nov 30, 2018
Financial News

Pharmasset, Idenix vets lead HBV company Antios to $25M series A

...Other investors included CAM Capital, Delos Capital, Quantum Vista Capital, Fonds de solidarité FTQ and Georgia Research Alliance Venture Fund...
BioCentury | Nov 27, 2018
Financial News

Pharmasset, Idenix vets lead HBV company Antios to $25M series A

...Other investors included CAM Capital, Delos Capital, Quantum Vista Capital, Fonds de solidarité FTQ and Georgia Research Alliance Venture Fund...
BioCentury | Dec 7, 2015
Financial News

Clearside Biomedical completes venture financing

...Cormorant Asset Management; Perceptive Advisors; Rock Springs Capital; RusnanoMedInvest; Hatteras Venture Partners; Mountain Group Capital; Georgia Research Alliance Venture Fund WIR...
BioCentury | Dec 4, 2015
Financial News

Clearside's series C brings $20M

...Springs Capital as well as existing investors RusnanoMedInvest, Hatteras Venture Partners, Mountain Group Capital and Georgia Research Alliance Venture Fund...
BioCentury | Jun 15, 2015
Financial News

Celtaxsys Inc. completes venture financing

...Type: Venture financing Raised: $40 million Investors: Domain Associates; Lumira Capital; RMI Partners; Masters Capital; Georgia Research Alliance Venture Fund...
BioCentury | Jun 15, 2015
Finance

Domain finds unmet need in CF

...Other investors in the round included Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund...
BioCentury | Jun 9, 2015
Financial News

Celtaxsys raises $40 million series D

...its Fund VIII. Also participating were Lumira Capital; RMI Partners; Masters Capital Management; and the Georgia Research Alliance Venture Fund...
BioCentury | Sep 8, 2014
Financial News

Clearside Biomedical completes venture financing

...$16 million Investors: RusnanoMedInvest; Hatteras Venture Partners; Santen Pharmaceutical Co. Ltd. ; Mountain Group Capital; Georgia Research Alliance Venture Fund WIR...
BioCentury | Sep 3, 2014
Financial News

Clearside raises $16 million B round

...RusnanoMedInvest. Existing investors Hatteras Venture Partners; Santen Pharmaceuticals Co. Ltd. (Tokyo:4536); Mountain Group Capital; and Georgia Research Alliance Venture Fund...
BioCentury | Feb 11, 2013
Financial News

Clearside Biomedical completes venture financing

...Raised: $7.9 million Investors: Santen Pharmaceutical Co. Ltd. ; Mountain Group Capital; Hatteras Venture Partners; Georgia Research Alliance Venture Fund...
Items per page:
1 - 10 of 10